0001209191-22-008911.txt : 20220211 0001209191-22-008911.hdr.sgml : 20220211 20220211164810 ACCESSION NUMBER: 0001209191-22-008911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220209 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lind Kevin Robert CENTRAL INDEX KEY: 0001677036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40192 FILM NUMBER: 22622065 MAIL ADDRESS: STREET 1: C/O ARENA PHARMACEUTICALS, INC. STREET 2: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Longboard Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001832168 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 950 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 619-592-9775 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 950 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-09 0 0001832168 Longboard Pharmaceuticals, Inc. LBPH 0001677036 Lind Kevin Robert 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 1 1 0 0 CEO Stock Option (Right to Buy) 4.20 2022-02-09 4 A 0 195000 0.00 A 2032-02-08 Voting common stock 195000 195000 D The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2022. /s/ Brandi L. Roberts, Attorney-In-Fact 2022-02-11